Unnamed: 0,title,date,stock,sentiment
41780.0,"Cramer Shares His Thoughts On Marriott, Tegna And More",2020-06-10 10:36:00-04:00,AGEN,positive
41781.0,"The Daily Biotech Pulse: Regulatory Delay For Novartis' Multiple Sclerosis Drug, FSD Gets Nod For COVID-19 Study",2020-06-03 07:39:00-04:00,AGEN,negative
41782.0,Stocks That Hit 52-Week Highs On Tuesday,2020-06-02 10:33:00-04:00,AGEN,neutral
41783.0,Agenus shares are trading higher after the company announced that the FDA cleared its IND application for iNKT cells to treat coronavirus patients.,2020-06-02 09:58:00-04:00,AGEN,positive
41784.0,Agenus Announces FDA Clears IND  Application For iNKT Cells to Treat COVID-19 Patients,2020-06-02 08:31:00-04:00,AGEN,positive
41785.0,72 Biggest Movers From Friday,2020-06-01 04:53:00-04:00,AGEN,neutral
41786.0,50 Stocks Moving In Friday's Mid-Day Session,2020-05-29 12:15:00-04:00,AGEN,neutral
41787.0,Agenus Reports FDA Clears AgenTus Investigational New Drug For Allogeneic iNKT Cell Therapy,2020-05-13 09:56:00-04:00,AGEN,positive
41788.0,Recap: Agenus Q1 Earnings,2020-05-07 08:29:00-04:00,AGEN,neutral
41789.0,"Agenus Q1 EPS $(0.310) Beats $(0.330) Estimate, Sales $15.130M Beat $12.350M Estimate",2020-05-07 08:08:00-04:00,AGEN,neutral
41790.0,"The Daily Biotech Pulse: FDA Approves Novartis Lung Cancer Drug, 2-Way Contest Emerging For Tetraphase Pharma, Dexcom To Join S&P 500",2020-05-07 07:41:00-04:00,AGEN,negative
41791.0,The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace,2020-05-03 08:45:00-04:00,AGEN,neutral
41792.0,Agenus Shares Spike To Session High On Uptick In Volume As Traders Circulate Chatter Co. Could 3D Print Respiratory Masks,2020-04-14 10:57:00-04:00,AGEN,positive
41793.0,Agenus Receives Fast Track Designation For Balstilimab In Advanced Cervical Cancer,2020-04-07 13:05:00-04:00,AGEN,negative
41794.0,Agenus Newsletter Says Co. Has Initiated Programs To 'Provide Therapeutic Benefit' For Coronavirus Patients,2020-04-07 12:51:00-04:00,AGEN,positive
41795.0,Stocks That Hit 52-Week Lows On Monday,2020-03-23 10:34:00-04:00,AGEN,negative
41796.0,"The Daily Biotech Pulse: AbbVie, Allergan Agree On Divestments, Obalon Stops Obesity Balloon Sale, COVID-19 Updates",2020-03-18 07:36:00-04:00,AGEN,positive
41797.0,Agenus Receives Fast Track Designation for Balstilimab & Zalifrelimab in Advanced Cervical Cancer,2020-03-12 07:46:00-04:00,AGEN,negative
41798.0,"The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO",2020-03-12 07:37:00-04:00,AGEN,negative
41799.0,108 Biggest Movers From Yesterday,2020-03-11 05:34:00-04:00,AGEN,neutral
41800.0,Agenus Highlights Triggering Of $15.1M Milestone Payment From HealthCare Royalty Partners,2020-03-10 09:16:00-04:00,AGEN,neutral
41801.0,Shares of several healthcare companies are trading higher as markets rebound following Monday's selloff. US President Trump on Monday indicated the US may implement payroll tax cuts and other measures to support the economy amid the coronavirus outbreak.,2020-03-10 07:54:00-04:00,AGEN,positive
41802.0,"The Week Ahead In Biotech (March 8-14): Bristol-Myers Awaits FDA Nod For Liver Cancer Combo Therapy, Earnings Flow Continues",2020-03-08 16:14:00-04:00,AGEN,negative
41803.0,60 Stocks Moving In Friday's Mid-Day Session,2020-03-06 12:11:00-05:00,AGEN,neutral
41804.0,Shares of several healthcare companies are trading lower as the global coronavirus spread continues to cause equities across sectors to sell off amid worsened economic outlook.,2020-02-28 09:06:00-05:00,AGEN,negative
41805.0,Shares of several healthcare companies are trading lower as growing coronavirus fears hamper economic outlook.,2020-02-27 09:28:00-05:00,AGEN,negative
41806.0,Shares of several healthcare and biotech companies are trading lower amid continued spread of coronavirus including notable upticks in Iran and Italy. NOTE: The virus has raised fear of a global economic slowdown.,2020-02-24 08:37:00-05:00,AGEN,negative
41807.0,95 Biggest Movers From Yesterday,2020-02-21 05:12:00-05:00,AGEN,neutral
41808.0,Agenus shares are trading lower. The company earlier reported data from balstilimab and zalifrelimab clinical trials.,2020-02-20 11:53:00-05:00,AGEN,neutral
41809.0,"UPDATE: Agenus Says Is On Track To Submit 2 Biologics License Applications For Balstilimab, Zalifrelimab In 2020",2020-02-20 09:58:00-05:00,AGEN,neutral
41810.0,"Agenus Reports Interim Data From Balstilimab, Zalifrelimab: Combo Yield Greater Than 20% Response Rates",2020-02-20 09:57:00-05:00,AGEN,positive
41811.0,"The Daily Biotech Pulse: Heron Pain Drug Review Extended, Disappointment For Teva In Tourette Syndrome Study",2020-02-20 07:06:00-05:00,AGEN,negative
41812.0,78 Biggest Movers From Yesterday,2020-02-20 05:16:00-05:00,AGEN,neutral
41813.0,Agenus shares are trading higher. Not seeing any company-specific news to justify the price action. NOTE: Stock is potentially trading higher in anticipation of tomorrow's investor day.,2020-02-19 15:32:00-05:00,AGEN,positive
41814.0,25 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2020-02-19 08:10:00-05:00,AGEN,neutral
41815.0,"The Week Ahead In Biotech: Baudax Bio, Merck, Esperion Await FDA Decisions",2020-02-16 15:03:00-05:00,AGEN,positive
41816.0,Agenus Commences Phase 1 trial With AGEN1223,2020-01-08 08:36:00-05:00,AGEN,neutral
41817.0,Agenus Reports Commencement Of Combo Trial Of CTLA-4 With PD-1 Antibody,2019-12-19 07:35:00-05:00,AGEN,neutral
41818.0,"The Daily Biotech Pulse: Endo's Cellulite Treatment Accepted For Review, Diffusion Pharma Reports Positive Glioblastoma Data",2019-11-20 07:25:00-05:00,AGEN,positive
41819.0,Stocks That Hit 52-Week Highs On Tuesday,2019-11-19 10:21:00-05:00,AGEN,neutral
41820.0,"B. Riley FBR Reinstates Buy on Agenus, Announces $6 Price Target",2019-11-19 08:28:00-05:00,AGEN,neutral
41821.0,72 Biggest Movers From Yesterday,2019-11-19 04:39:00-05:00,AGEN,neutral
41822.0,44 Stocks Moving In Monday's Mid-Day Session,2019-11-18 12:32:00-05:00,AGEN,neutral
41823.0,Stocks That Hit 52-Week Highs On Monday,2019-11-18 11:01:00-05:00,AGEN,neutral
41824.0,Stocks That Hit 52-Week Highs On Tuesday,2019-11-12 10:11:00-05:00,AGEN,neutral
41825.0,"The Daily Biotech Pulse: Reata, Kadmon Clinical Readouts, Apyx Medical's Earnings Beat",2019-11-12 07:20:00-05:00,AGEN,neutral
41826.0,Agenus to Receive a $10M Upfront Payment from UroGen Pharma to Advance Treatment of Urinary Tract Cancers,2019-11-11 08:14:00-05:00,AGEN,neutral
41827.0,"The Daily Biotech Pulse: Therapix Calls Off Merger, Alimera's Reverse Split, 2 Biotechs To Debut",2019-11-08 08:14:00-05:00,AGEN,neutral
41828.0,"Agenus Q3 EPS $(0.33) Beats $(0.38) Estimate, Sales $19.94M Beat $15.6M Estimate",2019-11-04 07:46:00-05:00,AGEN,neutral
41829.0,"Shares of several healthcare companies are trading lower, potentially on recent Democratic primary polls showing Senator Elizabeth Warren in the lead.",2019-09-26 12:43:00-04:00,AGEN,neutral
41830.0,Shares of many pharma/therapeutics stocks trading lower in sympathy with overall market weakness. Reports China is planning to cut prices for widely-used drugs may also be pressuring the sector today.,2019-09-24 14:01:00-04:00,AGEN,negative
41831.0,110 Biggest Movers From Yesterday,2019-08-09 05:15:00-04:00,AGEN,neutral
41832.0,90 Stocks Moving In Thursday's Mid-Day Session,2019-08-08 12:50:00-04:00,AGEN,neutral
41833.0,Agenus shares are trading higher after the company reported better-than-expected Q2 sales results.,2019-08-08 11:31:00-04:00,AGEN,positive
41834.0,"Agenus Q2 EPS $(0.38) Misses $(0.33) Estimate, Sales $15.715M Beat $5.36M Estimate",2019-08-08 10:05:00-04:00,AGEN,negative
41835.0,Agenus Reports $7.5M Payment Triggered Following Acceptance Of Investigational New Drug Application Filing For AGEN2373,2019-08-08 10:05:00-04:00,AGEN,positive
41836.0,33 Healthcare Stocks Moving In Today's Pre-Market Session,2019-07-30 09:16:00-04:00,AGEN,neutral
41837.0,"Agenus Q1 EPS $0.14 Which May Not Compare To $(0.29) Estimate, Sales $80M May Not Compare To $9.02M Estimate",2019-05-09 08:37:00-04:00,AGEN,neutral
41838.0,"The Daily Biotech Pulse: Novartis Goes Shopping, Mixed Trial Results For Provention Bio, 4 Stocks To Debut",2019-05-09 07:56:00-04:00,AGEN,neutral
41839.0,"Benzinga's Top Upgrades, Downgrades For April 22, 2019",2019-04-22 08:55:00-04:00,AGEN,positive
41840.0,"B. Riley FBR Initiates Coverage On Agenus with Buy Rating, Announces $5 Price Target",2019-04-22 06:51:00-04:00,AGEN,neutral
41841.0,Agenus Reports Dosing Of Next-Gen Anti-CTLA-4 Antibody Has Begun,2019-04-02 08:36:00-04:00,AGEN,neutral
41842.0,"Agenus Q4 EPS $(0.40) Misses $(0.28) Estimate, Sales $6.451M Miss $6.67M Estimate",2019-03-14 08:07:00-04:00,AGEN,negative
41843.0,"Agenus Reports Acceptance Of Co.'s IND Filing For AGEN1423 Partnership With Gilead, Triggering Cash Payment Of $7.5M",2019-03-13 08:33:00-04:00,AGEN,positive
41844.0,71 Biggest Movers From Yesterday,2019-02-20 04:49:00-05:00,AGEN,neutral
41845.0,Agenus Launches Asset-Backed Digital-Security,2019-02-19 08:34:00-05:00,AGEN,neutral
41846.0,Investor Movement Index January Summary,2019-02-05 13:14:00-05:00,AGEN,neutral
41847.0,Agenus To Launch First Asset-Backed Digital Security Offering,2019-01-29 08:16:00-05:00,AGEN,positive
41848.0,"Gilead Sciences Reports 9.3% Passive Stake In Agenus Inc As Of Jan 23, 2019",2019-01-29 06:21:00-05:00,AGEN,positive
41849.0,Agenus Closes $150 Million Immuno-oncology Transaction With Gilead,2019-01-24 08:43:00-05:00,AGEN,neutral
41850.0,48 Biggest Movers From Yesterday,2019-01-18 05:06:00-05:00,AGEN,neutral
41851.0,Agenus Reports Expansion Of Strategic Immuno-Oncology Alliance With Selexis,2019-01-09 10:31:00-05:00,AGEN,neutral
41852.0,58 Biggest Movers From Yesterday,2019-01-04 05:35:00-05:00,AGEN,neutral
41853.0,"Agenus Reports Was Granted ~$1M From Bill & Melinda Gates Foundation To Develop Alternative, Plant Cell Culture-Based Manufacturing Process For QS-21 Stimulon",2019-01-03 11:32:00-05:00,AGEN,positive
41854.0,33 Stocks Moving In Wednesday's Mid-Day Session,2018-12-26 12:37:00-05:00,AGEN,neutral
41855.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Afternoon Of Fri., Dec. 21, 2018",2018-12-21 12:03:00-05:00,AGEN,positive
41856.0,60 Biggest Movers From Yesterday,2018-12-21 05:11:00-05:00,AGEN,neutral
41857.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Afternoon Of Thurs., Dec. 20, 2018",2018-12-20 15:35:00-05:00,AGEN,positive
41858.0,Mid-Afternoon Market Update: Dow Tumbles 400 Points; DBV Technologies Shares Plummet,2018-12-20 14:47:00-05:00,AGEN,positive
41859.0,46 Stocks Moving In Thursday's Mid-Day Session,2018-12-20 12:37:00-05:00,AGEN,neutral
41860.0,Mid-Day Market Update: Crude Oil Down Over 3%; Agenus Shares Spike Higher,2018-12-20 12:13:00-05:00,AGEN,negative
41861.0,Mid-Morning Market Update: Markets Mostly Lower; Walgreens Earnings Top Expectations,2018-12-20 10:15:00-05:00,AGEN,negative
41862.0,Shares of Agenus are trading up 41.8% after the company announced a collaboration deal with Gilead to develop immuno-oncology therapies; Agenus is set to receive $150 million.,2018-12-20 09:31:00-05:00,AGEN,positive
41863.0,"Gilead, Agenus Report Collaboration Deal To Develop Immuno-Oncology Therapies; Agenus To Receive $150M",2018-12-20 07:31:00-05:00,AGEN,neutral
41864.0,48 Biggest Movers From Friday,2018-12-10 05:23:00-05:00,AGEN,neutral
41865.0,Agenus Names Jennifer Buell COO,2018-11-13 16:39:00-05:00,AGEN,neutral
41866.0,"Agenus Inc. Q3 EPS $(0.29) Misses $(0.25) Estimate, Sales $6.276M Miss $10.76M Estimate",2018-11-06 08:00:00-05:00,AGEN,negative
41867.0,Agenus Presents Clinical Data Showing Patients Treated With Agenus' PD-1 & CTLA-4 Antibodies Show Durable Clinical Benefit In Early Analyses at ESMO 2018,2018-10-20 16:36:00-04:00,AGEN,positive
41868.0,"The Week Ahead In Biotech: ESMO Conference, PDUFA Dates, Clinical Trial Results And IPOs",2018-10-14 13:21:00-04:00,AGEN,neutral
41869.0,26 Stocks Moving In Thursday's Pre-Market Session,2018-10-11 09:10:00-04:00,AGEN,neutral
41870.0,30 Stocks Moving In Friday's Pre-Market Session,2018-09-21 08:09:00-04:00,AGEN,neutral
41871.0,"XOMA Reports Purchase Of Royalty Interest Position From Agenus On 7 Assets Being Developed By Merck, Incyte For $15M",2018-09-21 07:00:00-04:00,AGEN,positive
41872.0,"Agenus 8-K Shows License, Development, Commercialization Deal With Incyte; Co. Remains Eligible To Receive Up To $505M In Potential Milestones, Plus Royalties On Future Sales Ranging From 6-15%",2018-09-21 06:37:00-04:00,AGEN,neutral
41873.0,Agenus Receives $5M Milestone Payment from Incyte For Start Of Phase 1 Trail of LAG-3 Antibody,2018-09-17 09:06:00-04:00,AGEN,neutral
41874.0,Agenus Receives a $5M Milestone Payment from Incyte,2018-09-17 09:04:00-04:00,AGEN,neutral
41875.0,"Stocks Which Set New 52-Week Low Yesterday, August 16th",2018-08-17 10:40:00-04:00,AGEN,negative
41876.0,Agenus Receives Milestone Payment From Merck Of $4M For Initiation Of Phase 1 Clinical Trial Of An Undisclosed Antibody Candidate Discovered By Agenus,2018-08-15 13:25:00-04:00,AGEN,neutral
41877.0,"Agenus Q2 EPS $(0.24) Beats $(0.40) Estimate, Sales $10.47M Doesn't Compare To $1.52M Estimate",2018-08-09 08:09:00-04:00,AGEN,neutral
41878.0,"Stocks Which Set New 52-Week Low Yesterday, August 6th",2018-08-07 11:28:00-04:00,AGEN,negative
41879.0,"The Daily Biotech Pulse: FDA Snub For Gemphire, Ligand Earnings, Insmed's Antibiotic Faces FDA Panel",2018-08-07 08:23:00-04:00,AGEN,negative
41880.0,"Stocks Which Set New 52-Week Lows Friday, August 3rd",2018-08-06 13:20:00-04:00,AGEN,negative
41881.0,"Stocks Which Set New 52-Week Low Friday, July 27",2018-07-30 12:17:00-04:00,AGEN,negative
41882.0,"Stocks Which Set New 52-Week Low Yesterday, July 26th:",2018-07-27 10:54:00-04:00,AGEN,negative
41883.0,"Benzinga's Daily Biotech Pulse: Achaogen To Trim Workforce By 28%, Amgen's Beat-And-Raise Quarter",2018-07-27 08:44:00-04:00,AGEN,neutral
41884.0,"Stocks Which Set New 52-Week Lows Yesterday, July 24th:",2018-07-25 12:17:00-04:00,AGEN,negative
41885.0,"Benzinga's Daily Biotech Pulse: Merck's Keytruda Found Effective, Nabriva To Acquire Zavante, FDA Denies Agile",2018-07-25 08:41:00-04:00,AGEN,positive
41886.0,"Benzinga's Daily Biotech Pulse: Bellicum CFO Resigns, Roche's Trial Meets Endpoints, Avid Bioservices Turns To Black In Q4",2018-07-17 08:37:00-04:00,AGEN,neutral
41887.0,"Benzinga's Daily Biotech Pulse: Epidiolex, Roche's Influenza Drug Gets Priority Review Status, Xeris Jumps On Positive Trial Results",2018-06-26 08:34:00-04:00,AGEN,positive
41888.0,26 Stocks Moving In Tuesday's Pre-Market Session,2018-06-26 08:00:00-04:00,AGEN,neutral
41889.0,25 Stocks Moving In Monday's Pre-Market Session,2018-06-25 08:27:00-04:00,AGEN,neutral
41890.0,"Benzinga's Daily Biotech Pulse: FDA Greenlights Tandem Diabetes' Insulin Pump, More IPOs On Tap",2018-06-22 08:51:00-04:00,AGEN,neutral
41891.0,25 Stocks Moving In Friday's Pre-Market Session,2018-06-22 08:02:00-04:00,AGEN,neutral
41892.0,"Benzinga's Daily Biotech Pulse: Sarepta's DMD Gene Therapy, Anika's Flunked Trial, Eidos To Commence Trading",2018-06-20 08:36:00-04:00,AGEN,negative
41893.0,"Benzinga's Daily Biotech Pulse: vTv Swoons On Failed Alzheimer's Trial, Regenxbio Gets FDA Fast Track For RGX-111",2018-06-13 07:48:00-04:00,AGEN,negative
41894.0,"Benzinga's Daily Biotech Pulse: Galmed Rips Higher On Positive NASH Data, Enzo Biochem Falls On Earnings, Pfenex Licenses Osteoporosis Candidate",2018-06-12 08:47:00-04:00,AGEN,positive
41895.0,The Week Ahead In Biotech: ASCO Presentations Dominate The Headlines,2018-06-03 19:27:00-04:00,AGEN,negative
41896.0,"Benzinga's Daily Biotech Pulse: Transenterix Rises, Mylan Earnings, Deutsche Bank Conference Underway",2018-05-09 07:48:00-04:00,AGEN,neutral
41897.0,31 Biggest Movers From Yesterday,2018-05-08 05:12:00-04:00,AGEN,neutral
41898.0,Agenus Q1 EPS $(0.53) Misses $(0.30) Estimate,2018-05-07 09:01:00-04:00,AGEN,negative
41899.0,38 Biggest Movers From Yesterday,2018-04-17 04:46:00-04:00,AGEN,neutral
41900.0,"Agenus Reports Q4 EPS $(0.35) vs $(0.29) Est., Sales $8.354M vs $12.7M Est.",2018-03-15 08:32:00-04:00,AGEN,neutral
41901.0,Agenus Shares Up 5.56%; Earlier Co. Announced $230M Royalty From HealthCare Royalty Partners,2018-01-08 13:11:00-05:00,AGEN,positive
41902.0,"Agenus Receives License Fee of $4M from Merck, Entitled Up To An Additional $99M in Success Milestones Plus Royalties On Sales",2017-11-15 09:29:00-05:00,AGEN,positive
41903.0,Agenus Reports Shingrix With Qs-21 Stimulon Received Positive Recommendation From CDC's AdCom On Immunization Practices As Preferred Vaccine For Prevention Of Shingles,2017-10-25 17:03:00-04:00,AGEN,positive
41904.0,"JMP Out With A Note On Agenus, Says Shares Should  See Significant Upside In Shares Should Any One Of its Many Programs Read-Out Positively; Says Weakness Is In Reaction To Competitor Agreement",2017-10-25 15:02:00-04:00,AGEN,positive
41905.0,"Agenus Shares Spike To Afternoon Highs, Up 2.7% Over Last Few Mins. As Traders Circulate Reuters Article From Earlier 'US committee recommends GSK shingles vaccine over Merck rival'",2017-10-25 14:58:00-04:00,AGEN,positive
41906.0,40 Biggest Movers From Yesterday,2017-10-25 05:31:00-04:00,AGEN,neutral
41907.0,32 Stocks Moving In Monday's Mid-Day Session,2017-10-23 12:31:00-04:00,AGEN,neutral
41908.0,Agenus Bio CEO to Appear on Mad Money with Jim Cramer Tonight,2017-10-23 12:22:00-04:00,AGEN,negative
41909.0,The Week Ahead: Earnings Season Starts In Earnest,2017-10-23 09:00:00-04:00,AGEN,positive
41910.0,25 Stocks Moving In Monday's Pre-Market Session,2017-10-23 08:03:00-04:00,AGEN,neutral
41911.0,Agenus +19% Premarket @$5.15; GSK's Shingle Vaccine Receives FDA Approval,2017-10-23 06:17:00-04:00,AGEN,positive
41912.0,GSK's Shingle Vaccine Shingrix Receives US FDA Approval,2017-10-23 06:14:00-04:00,AGEN,positive
41913.0,Agenus Shares Down 7.85% On ~3x Avg. Volume; Wed. Co. Filed For $250M Mixed Offering,2017-10-19 14:04:00-04:00,AGEN,positive
41914.0,"Agenus Reports Health Canada Granted Marketing Authorization To Glaxo's Shingrix, Which Contains Co.'s Proprietary Immune Adjuvant QS-21",2017-10-13 14:12:00-04:00,AGEN,positive
41915.0,"Attention Biotech Investors, Here's Your PDUFA Primer For October",2017-09-28 10:51:00-04:00,AGEN,neutral
41916.0,"Agenus Reports Q2 EPS $(0.32) vs $(0.37) Est., Sales $4.2M vs $5M Est.",2017-08-03 08:52:00-04:00,AGEN,neutral
41917.0,Watch These 7 Huge Call Purchases In Monday Trade,2017-07-03 04:23:00-04:00,AGEN,positive
41918.0,Benzinga's Option Alert Recap From June 30,2017-06-30 16:10:00-04:00,AGEN,positive
41919.0,Option Alert: Agenus Jul 5.0 Calls Sweep: 1009 @  ASK  $0.10: 1376 traded vs 200 OI:  Earnings 8/3 Before Open (est)  $3.88 Ref,2017-06-30 14:10:00-04:00,AGEN,positive
41922.0,"Agenus Issues Release Highlighting Anti-CTLA-4 Antibody Showed Strong Safety, Tolerability",2017-06-05 12:31:00-04:00,AGEN,positive
41923.0,Option Alert: Agenus Nov 6.0 Calls Sweep: 500 @  ASK  $0.10: 500 traded vs 88 OI:  Earnings 8/3 Before Open (est)  $3.35 Ref,2017-05-30 10:51:00-04:00,AGEN,positive
41924.0,Agenus Reports 1st Patient Dosed In Anti-PD-1 Combination Trial with AGEN2034,2017-04-20 08:51:00-04:00,AGEN,neutral
41925.0,"Agenus CEO Garo H Armen Buys 100,000 Shares @ Avg Price: $3.35 (Form4)",2017-04-12 17:44:00-04:00,AGEN,positive
41926.0,Agenus Reports Commencement of Phase 1 Trial with AutoSynVax,2017-04-05 08:50:00-04:00,AGEN,neutral
41927.0,"UPDATE: Agenus Plans to Close basel Site, Consolidate Key Functions to Cambridge, UK, Lexington, MA Plants, Phase Out ~50 Jobs",2017-03-30 06:54:00-04:00,AGEN,neutral
41928.0,"Agenus Reports Reorganization of Business, Operations to Sharpen Focus on Clinical Development of 2 Checkpoint Inhibitor Antibodies, Vaccine Program",2017-03-30 06:54:00-04:00,AGEN,negative
41929.0,"Agenus Reports Q4 EPS $(0.30) vs. $(0.30) Est., Sales $5.57M vs. $6.05M Est.",2017-03-09 08:53:00-05:00,AGEN,neutral
41930.0,Agenus Announces Accrual for Phase II trial of Prophage G-200 vaccine in combination with bevacizumab in Patients with Surgically Resectable Recurrent Glioblastoma Multiforme has been Closed,2017-02-21 16:57:00-05:00,AGEN,neutral
41931.0,18 Biggest Mid-Day Gainers For Tuesday,2017-02-14 12:28:00-05:00,AGEN,neutral
41932.0,Agenus Gets A Boost From Incyte Cash Infusion,2017-02-14 11:57:00-05:00,AGEN,positive
41933.0,20 Stocks Moving In Tuesday's Pre-Market Session,2017-02-14 08:33:00-05:00,AGEN,neutral
41934.0,Adam Feuerstein Tweets: $AGEN forced to amend its cancer immunotherapy collaboration w/ $INCY bc co. needs money now. Shows lack of confidence.,2017-02-14 07:17:00-05:00,AGEN,negative
41935.0,UPDATE: Agenus Will Receive $80M from Incyte,2017-02-14 07:02:00-05:00,AGEN,neutral
41936.0,"Incyte, Agenus Report Amended Collaboration Deal for Development, Commercialization Responsibilities for GITR, OX40 Programs",2017-02-14 07:02:00-05:00,AGEN,neutral
41937.0,"Agenus Names Jean-Marie Cuillerot, M.D. Chief Medical Officer",2017-01-30 09:00:00-05:00,AGEN,neutral
41938.0,Agenus Announces Collaboration with the National Cancer Institute to Evaluate the Combination of Pembrolizumab with Prophage,2017-01-17 09:02:00-05:00,AGEN,negative
41939.0,Agenus Announces Commencement of Phase 1/2 Clinical Trial of anti-OX40 Checkpoint Antibody INCAGN1949 in Patients with Solid Tumors,2016-11-30 08:51:00-05:00,AGEN,positive
41940.0,7 Biggest Price Target Changes For Friday,2016-10-28 09:37:00-04:00,AGEN,neutral
41941.0,"H.C. Wainwright Downgrades Agenus Inc. - Common Stock to Neutral, Lowers to $5.00",2016-10-28 07:33:00-04:00,AGEN,negative
41942.0,"Agenus Reports Q3 EPS $(0.47) vs $(0.30) Est., Sales $4.446M",2016-10-27 08:55:00-04:00,AGEN,neutral
41943.0,18 Stocks Moving In Monday's Pre-Market Session,2016-10-24 08:25:00-04:00,AGEN,neutral
41944.0,"Director Wiinberg Buys 30,000 Shares of Agenus @$6.29/Share -Form 4",2016-09-08 15:33:00-04:00,AGEN,positive
41945.0,Watch These 7 Huge Call Purchases In Friday Trade,2016-08-12 01:48:00-04:00,AGEN,positive
41946.0,Option Alert: AGEN Sep16 7.0 Calls Sweep: 1815 @  ASK  $0.25: 1815 traded vs 27 OI: $5.86 Ref,2016-08-11 15:02:00-04:00,AGEN,positive
41947.0,Agenus Sells off to Low of $5.53 on Volume,2016-08-01 10:47:00-04:00,AGEN,negative
41948.0,Agenus Reports Start of Phase 1/2 Clinical Trial of anti-GITR Checkpoint Antibody INCAGN1876 in Patients with Solid Tumors,2016-06-22 08:50:00-04:00,AGEN,positive
41949.0,"Agenus Reports Lead Product Candidate Selection in its Collab with Merck, Received First Milestone Payment of $2M",2016-06-09 08:50:00-04:00,AGEN,neutral
41950.0,"Chairman Armen Buys 100,000 Shares of Agenus @$3.18/Share -Form 4",2016-05-10 09:24:00-04:00,AGEN,positive
41951.0,"Agenus Reports Q1 EPS $(0.37) vs $(0.23) Est., Sales $5.959M vs $5.16M Est.",2016-04-28 08:51:00-04:00,AGEN,neutral
41952.0,"Achaogen Reports Acceleration of Expected Timeline for Reporting Top-Line Results from Phase 3 EPIC Registration Trial of Plazomicin: Sees Completion of Enrollment in '16, Data in Q1'17, NDA Submission 2H'17",2016-04-05 08:03:00-04:00,AGEN,neutral
41953.0,Agenus Shares Spike Higher Following Mid-Day Upgrade To Buy From Maxim,2016-03-12 12:04:00-05:00,AGEN,positive
41954.0,NOTE: Agenus Chairman Reported 200K Share Buy in Form 4 Filing on March 8,2016-03-11 13:23:00-05:00,AGEN,positive
41955.0,Agenus Spikes to High of $4.05; May be Attributed to Upgrade at Maxim With $7 PT,2016-03-11 13:20:00-05:00,AGEN,neutral
41956.0,UPDATE: Agenus Shares Spike to $4.13 on Form 4 Filing by CEO Showing 200K Share Buy,2016-03-08 11:39:00-05:00,AGEN,positive
41957.0,"Chmn Armen Buys 200,000 Of Agenus @$4.03/Share -Form 4",2016-03-08 11:37:00-05:00,AGEN,neutral
41958.0,Option Alert: AGEN Jan17 5.0 Calls Sweep: 1236 @  ASK  $0.60: 7325 traded vs 972 OI:  Earnings today Before Open  $3.40 Ref,2016-03-03 11:54:00-05:00,AGEN,positive
41959.0,"Agenus Reports Q4 EPS $(0.18) vs $(0.17) Est., Sales $7.639M vs $9.4M Est.",2016-03-03 07:04:00-05:00,AGEN,neutral
41960.0,"Agenus Reports Clearance of INDA for anti-CTLA-4, anti-GITR Antibodies",2016-01-21 07:59:00-05:00,AGEN,neutral
41961.0,Agenus Acquires PhosImmune For $2.5M Cash And $7.4M In Agenus Stock; Additional Payments Of $35M In Cash/Stock Eligible On Achievement Of Certain Milestones,2015-12-23 16:01:00-05:00,AGEN,positive
41962.0,S-3 from Agenus Shows Registration for ~7.764M Shares of Common Stock via Selling Holders,2015-11-20 16:07:00-05:00,AGEN,positive
41963.0,SOMA To Sell Manufacturing Facilities To Agenus,2015-11-05 16:11:00-05:00,AGEN,neutral
41964.0,GSK's candidate Shingles Vaccine Containing Agenus' QS-21 Stimulon Shows 90% Efficacy against Shingles and 89% Efficacy against Post-Herpetic Neuralgia in Adults aged 70 Years and Older,2015-10-27 07:14:00-04:00,AGEN,neutral
41965.0,"Agenus Reports Q3 EPS $(0.16) vs. Est. $(0.11), Rev. $6.8M vs. Est. $7.56M",2015-10-27 07:01:00-04:00,AGEN,neutral
41966.0,Agenus Inc. Completes $115M Non-Dilutive Royalty Transaction with Oberland Capital,2015-09-09 07:02:00-04:00,AGEN,neutral
41967.0,GSK's Malaria Vaccine With Agenus' QS-21 Stimulon Receives Positive CHMP Opinion for Prevention of Malaria in Young Children,2015-07-24 04:42:00-04:00,AGEN,positive
41968.0,"Agenus Reports Q2 EPS $(0.53) vs. Est. $(0.15), Rev. $6.377M vs. Est. $5.71M; Estimates May Not Compare",2015-07-23 07:17:00-04:00,AGEN,neutral
41969.0,Agenus Acquires Rights To Antibodies Targeting CEACAM1 From Diatherva,2015-07-20 07:04:00-04:00,AGEN,neutral
41970.0,Did Anyone Notice Sucampo's Breakout?,2015-07-13 15:09:00-04:00,AGEN,neutral
41971.0,Agenus Shares Gap Lower; May be Attributed to Negative Adam F/Street.com Article,2015-06-23 12:57:00-04:00,AGEN,negative
41972.0,Agenus to Present at the 2015 JMP Securities Life Sciences Conference,2015-06-18 15:37:00-04:00,AGEN,positive
41973.0,Agenus Shares Falling on Volume,2015-06-18 15:10:00-04:00,AGEN,positive
41974.0,Agenus Names C. Evan Ballantyne CFO,2015-06-17 07:00:00-04:00,AGEN,neutral
41975.0,Benzinga's Top Initiations,2015-06-11 10:04:00-04:00,AGEN,positive
41976.0,"Oppenheimer Initiates Coverage on Agenus at Outperform, Announces $14.00 PT",2015-06-11 07:12:00-04:00,AGEN,neutral
41977.0,3 Stocks That Made A Big Impact At ASCO,2015-06-03 11:55:00-04:00,AGEN,neutral
41978.0,"US Stock Futures Surge Ahead Of ADP Report, Beige Book",2015-06-03 07:30:00-04:00,AGEN,neutral
41979.0,Merck Extends Immuno-Oncology Collaboration with Agenus,2015-06-03 07:03:00-04:00,AGEN,positive
41980.0,"Updated Phase 2 Data of Prophage In Newly Diagnosed GBM Presented at ASCO Show Improvement in Median Progression Free Survival and Overall Survival Independently of Prognostic Markers, Compared with Historical Expectations",2015-06-01 07:04:00-04:00,AGEN,positive
41981.0,Agenus Prices Offering Of 11M Shares At $6.30/Share,2015-05-21 09:27:00-04:00,AGEN,positive
41982.0,8-K from Agenus Shows Phase 3 Trial of HZ/su Demonstrated Reduced Risk of Shingles by 97.2% in Adults 50+ Compared to Placebo,2015-04-28 07:12:00-04:00,AGEN,negative
41983.0,NEJM Publishes Study Showing GSK's Shingles Vaccine Containing Agenus' QS-21 Stimulon® Adjuvant Provides over 97% Protection in People Over the Age of 50,2015-04-28 07:10:00-04:00,AGEN,neutral
41984.0,GSK's Malaria Vaccine Phase 3 Study Containing Agenus' QS-21 Published in The Lancet,2015-04-24 07:05:00-04:00,AGEN,neutral
41985.0,"Agenus Reports Q1 Loss of $0.28/Share, May Not Compare to Loss of $0.01/Share Est.",2015-04-23 07:12:00-04:00,AGEN,negative
41986.0,"Agenus Announces Acquisition of Celexion, Terms Not Disclosed",2015-04-08 07:01:00-04:00,AGEN,neutral
41987.0,"Agenus Q4 EPS -$0.41 vs -$0.16, May Not Compare",2015-02-26 07:08:00-05:00,AGEN,neutral
41988.0,Biotech Stocks Moving Higher,2015-02-23 15:35:00-05:00,AGEN,neutral
41989.0,UPDATE: Incyte Filing on Agenus Shows Language Discussing Standstill Provisions for Allowance of Co. to Acquire Up to 15% of Agenus's Outstanding Voting Shares,2015-02-20 16:13:00-05:00,AGEN,positive
41990.0,13G Filing from Incyte on Agenus Shows 11% Stake,2015-02-20 16:12:00-05:00,AGEN,neutral
41991.0,10 Biotech Stories You Might've Missed This Week,2015-01-15 13:18:00-05:00,AGEN,negative
41992.0,Mid-Afternoon Market Update: Five Below Slips On Weak Outlook; Agenus Shares Spike Higher,2015-01-09 15:41:00-05:00,AGEN,negative
41993.0,Mid-Day Market Update: Dow Dips 1%; Acuity Brands Shares Jump On Earnings Beat,2015-01-09 13:33:00-05:00,AGEN,positive
41994.0,Mid-Morning Market Update: Markets Decline; Infosys Posts Higher Profit,2015-01-09 10:49:00-05:00,AGEN,positive
41995.0,Stocks Hitting 52-Week Highs,2015-01-09 10:14:00-05:00,AGEN,neutral
41996.0,Morning Market Gainers,2015-01-09 09:43:00-05:00,AGEN,neutral
41997.0,"Agenus Announces Partnership With Incyte, Up to $350M of Milestones",2015-01-09 07:03:00-05:00,AGEN,neutral
41998.0,Morning Market Movers,2014-12-18 09:40:00-05:00,AGEN,neutral
41999.0,"#PreMarket Movers From December 18, 2014: Rite Aid, Oracle, GoPro And More",2014-12-18 09:08:00-05:00,AGEN,neutral
42000.0,Phase 3 Study of GSK Shingles Vaccine Containing Agenus Adjuvant Met Primary Endpoint; Agenus Shares +8.5% Premarket,2014-12-18 08:19:00-05:00,AGEN,positive
42001.0,White House Will Be Sending Ebola Funding Request to Congress Today,2014-11-05 11:01:00-05:00,AGEN,neutral
42002.0,WHO Says ~13.5K Confirmed or Suspected Cases of Ebola Come Out of Eight Countries,2014-10-31 13:36:00-04:00,AGEN,negative
42003.0,Agenus Inc. Reports Q3 EPS of $(0.13) vs $(0.15) Est; Revenue of $1.56M vs $1.96M Est,2014-10-31 07:05:00-04:00,AGEN,neutral
42004.0,CDC Will Hold Conference on Ebola at 3:30 p.m. EDT,2014-10-27 14:45:00-04:00,AGEN,neutral
42005.0,"White House's Earnest Says CDC Will Later Today Offer Update, More Info on Protocols for Handling Returning Workers",2014-10-27 13:16:00-04:00,AGEN,positive
42006.0,"Bellevue Hospital Issues Statement: Confirms 5-Yr Old Boy in Isolation Was in West Africa Within Last 21 Days, Test Results Expected Within 12 Hrs.",2014-10-27 09:22:00-04:00,AGEN,negative
42007.0,"Man Being Tested at Hospital in Tokyo, Japan After Exhibiting Fever",2014-10-27 08:40:00-04:00,AGEN,neutral
42008.0,Recent SkyNews Headlines Suggesting Pres Obama is Considering Quarantining Health Workers Back from West Africa,2014-10-24 15:17:00-04:00,AGEN,neutral
42009.0,NYC Mayor Currently Giving Press Conference on Ebola Case Being 'Under Control',2014-10-24 12:34:00-04:00,AGEN,positive
42010.0,Statement from NYC Official Says 'Preliminary Test Results' from Patient at Bellevue Hospital 'Expected in the Next 12 Hours',2014-10-23 15:24:00-04:00,AGEN,neutral
42011.0,"US Has Limited Visitors from Nations with Ebola Outbreaks to Five Airports, 94% of Travelers from These Countries Will Move Thru Airports",2014-10-21 11:34:00-04:00,AGEN,negative
42012.0,CDC Will Tighten Ebola Protection Guidelines for Health Workers,2014-10-17 16:00:00-04:00,AGEN,neutral
42013.0,"Hearing Possible Ebola Situation at Pentagon, Arlington County Hazmat Team on Scene",2014-10-17 12:25:00-04:00,AGEN,neutral
42014.0,WHO Declares End to Ebola Outbreak in Senegal,2014-10-17 09:30:00-04:00,AGEN,neutral
42015.0,Southwestern College Tweets: 'A precaution has been taken regarding a student whose family member reported flu-like symptoms and was hospitalized http://ow.ly/CSgUQ',2014-10-16 13:54:00-04:00,AGEN,neutral
42016.0,NBC7 San Diego Tweets '#BREAKING: Southwestern College evacuates students from one building http://on.nbc7.com/l75B2A3',2014-10-16 13:50:00-04:00,AGEN,neutral
42017.0,"WHO Sees 'Deteriorating' Situation in Liberia, Sierra Leone, Guinea",2014-10-15 13:21:00-04:00,AGEN,neutral
42018.0,"WHO Offers Comment on Transmission of African Ebola: Countries Include US, Spain, Nigeria, Liberia, Sierra Leone, Guinea, Senegal",2014-10-15 13:20:00-04:00,AGEN,neutral
42019.0,HHS Secretary Sylvia Mathews Burwell at CDC Briefing Says Patient at Texas Health Presbyterian Hospital Will Be Transferred to Emory University Today,2014-10-15 12:56:00-04:00,AGEN,neutral
42020.0,"Michael Boyd Of The Boyd Group On CNBC Speaking On Ebola Impact To Airliners Says ""This Is A Scare That WIll Evaporate""",2014-10-15 12:52:00-04:00,AGEN,negative
42021.0,"Source from Barcelona-El Prat Airport Confirms There Has Been No Ebola-Related Emergency, Spokesperson at Aena Says Has Not Received Alert from Airports About Potential Incident",2014-10-15 12:43:00-04:00,AGEN,negative
42022.0,CDC Will Hold Event Related to Ebola Response at 12:45 p.m. EDT,2014-10-15 12:18:00-04:00,AGEN,neutral
42023.0,"Doug Kass Tweeting: 'News services: *BARCELONA AIRPORT UNDER QUARANTINE AS 6 PASSENGERS CONFIRMED   POSITIVE FOR EBOLA VIRUS""'",2014-10-15 10:51:00-04:00,AGEN,positive
42024.0,WSJ Running Story 'EU Health Ministers to Consider Ebola Screening Across Continent',2014-10-15 09:58:00-04:00,AGEN,neutral
42025.0,UPDATE: Mayor Says Latest Ebola Case Patient Was Related to Care of Ebola Victim Duncan,2014-10-15 08:16:00-04:00,AGEN,positive
42026.0,"Dallas Mayor Currently Holding Press Conference: 48 Individuals Being Monitored, None Showing Symptoms, Warns 'It May Get Worse Before It Gets Better'",2014-10-15 08:15:00-04:00,AGEN,neutral
42027.0,"Texas Health Commission Saying Dallas Nurse is Showing No Symptoms of Ebola, No Added Cases Have Been Detected",2014-10-14 15:28:00-04:00,AGEN,negative
42028.0,"AP Tweets: 'MORE: WHO official says if response to the Ebola crisis isn't stepped up within 60 days, more people will die: http://apne.ws/1v7WaVO '",2014-10-14 08:51:00-04:00,AGEN,negative
42029.0,"AP Tweets: 'BREAKING: WHO says there could be up to 10,000 new cases of Ebola per week in 2 months.'",2014-10-14 08:50:00-04:00,AGEN,neutral
42030.0,Agenus Inc - A Potential New Play On Ebola,2014-10-13 13:01:00-04:00,AGEN,positive
42031.0,CDC Holding Daily Briefing: Texas Health Care Worker is in Stable Condition,2014-10-13 12:10:00-04:00,AGEN,positive
42032.0,Agenus Shares Spike to High; Note Being Passed Around Mentions it as Potential Ebola Play,2014-10-13 11:39:00-04:00,AGEN,positive
42033.0,S-3 from Agenus Shows Registration for $150M Mixed Securities Shelf Offering,2014-10-10 16:19:00-04:00,AGEN,positive
42034.0,Agenus Inc. Reports Q2 EPS of $(0.12) vs $(0.17) Est,2014-07-24 07:04:00-04:00,AGEN,neutral
42035.0,Agenus Announces Vaccine Candidate for Malaria Accepted for EU Regulatory Review ,2014-07-24 06:16:00-04:00,AGEN,positive
42036.0,Morning Market Movers ,2014-07-01 09:35:00-04:00,AGEN,neutral
42037.0,UPDATE: Agenus Shares Rise 26% Premarket Following Report of Positive Phase 2 Results,2014-07-01 08:09:00-04:00,AGEN,positive
42038.0,"US Stock Futures Gain Ahead Of Manufacturing PMI, Auto Sales",2014-07-01 07:35:00-04:00,AGEN,positive
42039.0,UPDATE: Agenus Announces Positive Phase 2 Results,2014-07-01 07:03:00-04:00,AGEN,positive
42040.0,Agenus Announces Positive Phase 2 Results,2014-07-01 07:00:00-04:00,AGEN,positive
42041.0,Morning Market Movers ,2014-06-26 09:37:00-04:00,AGEN,neutral
42042.0,Benzinga's Top #PreMarket Gainers,2014-06-26 08:15:00-04:00,AGEN,positive
42043.0,Agenus Spikes ~9% On Vaccine news,2014-06-26 07:05:00-04:00,AGEN,neutral
42044.0,UPDATE: Agenus Vaccine Shows Significant Reduction in Viral Burden after HerpV Generated Immune Activation,2014-06-26 07:01:00-04:00,AGEN,neutral
42045.0,Agenus Vaccine Shows Significant Reduction in Viral Burden after HerpV Generated Immune Activation,2014-06-26 07:01:00-04:00,AGEN,neutral
42046.0,"Events Scheduled for Week of Jun 23rd to Jun 27th, 2014",2014-06-23 18:25:00-04:00,AGEN,neutral
42047.0,S-3 Filing from Agenus Files 3.72M Share Offering for Selling Holders,2014-05-09 17:10:00-04:00,AGEN,positive
42048.0,Agenus Inc. Reports Q1 EPS of $(0.01) vs $(0.13) Est; Revenue of $721.0K vs $550.0K Est,2014-05-08 07:10:00-04:00,AGEN,neutral
42049.0,"Agenus Announces License Deal with Merck Related to Novel Checkpoint Antibody-Based Cancer Immunotherapies, Eligible for ~$100M in Milestone Payments",2014-04-28 07:17:00-04:00,AGEN,negative
42050.0,"McNicoll Lewis Vlak Maintains Buy on Agenus Inc., Lowers PT to $6.00",2014-04-03 06:52:00-04:00,AGEN,negative
42051.0,Morning Market Losers ,2014-04-02 09:55:00-04:00,AGEN,negative
42052.0,Agenus Provides Update on GSK'S MAGE-A3 Cancer Immunotherapeutic Phase 3 Study in NSCLC,2014-04-02 05:42:00-04:00,AGEN,negative
42053.0,Morning Market Losers ,2014-03-20 09:46:00-04:00,AGEN,negative
42054.0,"Adam Feuerstein tweets: 'Thx, I don't see a favorable risk/reward in a company which has never proven capable of doing anything right. $AGEN @hydrogenblimp'",2014-03-20 08:53:00-04:00,AGEN,negative
42055.0,US Stock Futures Drop Ahead Of Jobless Claims Report,2014-03-20 07:25:00-04:00,AGEN,negative
42056.0,Agenus Therapeutics Reports GlaxoSmithKline's Magrit Study Does Not Meet First or Second Primary Endpoint,2014-03-20 06:12:00-04:00,AGEN,neutral
42057.0,Agenus Says Will Advance Three Checkpoint Antibodies Into Development,2014-03-05 07:03:00-05:00,AGEN,neutral
42058.0,Agenus Inc. Reports Q4 EPS of $(0.16) vs $(0.24) Est,2014-03-05 07:01:00-05:00,AGEN,neutral
42059.0,UPDATE: H.C. Wainwright & Co. Initiates Coverage on Agenus Following 4-Antibody Acquisition,2014-02-24 07:55:00-05:00,AGEN,neutral
42060.0,"HC Wainwright Initiates Coverage on Agenus Inc. at Buy, Announces $8.00 PT",2014-02-24 07:05:00-05:00,AGEN,neutral
42061.0,Agenus Completes Acquisition of 4-Antibody ,2014-02-13 07:07:00-05:00,AGEN,neutral
42062.0,"Agenus Closes Offering of Shares, Net Proceeds $56M",2014-02-10 10:01:00-05:00,AGEN,positive
42063.0,Agenus Prices 19.3M Shares at $2.70/Share,2014-02-05 09:31:00-05:00,AGEN,positive
42064.0,Agenus Announces Public Offering of Common Stock,2014-02-04 17:05:00-05:00,AGEN,neutral
42065.0,Agenus Announces Public Offering of Common Shares,2014-02-04 17:05:00-05:00,AGEN,positive
42066.0,Agenus Spikes on CNBC Mention,2014-01-23 13:19:00-05:00,AGEN,neutral
42067.0,Agenus Announces Phase 2 Checkpoint Inhibitor Combo Trial with Prophage Vaccine for Melanoma,2014-01-14 07:12:00-05:00,AGEN,negative
42068.0,Agenus Names Robert B. Stein as Chief Scientific Officer ,2014-01-13 07:20:00-05:00,AGEN,neutral
42069.0,Agenus to Acquire Privately Held 4-Antibody AG for $10M in Stock,2014-01-13 07:11:00-05:00,AGEN,neutral
42070.0,Hearing Maxim Gives $19 PT to Agenus Following Announcement of Publication of Positive Brain Cancer Vaccine Data,2013-12-16 09:58:00-05:00,AGEN,negative
42071.0,Agenus Announces Positive Phase 2  Brain Cancer Vaccine Results Published in Neuro-Oncology ,2013-12-16 07:04:00-05:00,AGEN,negative
42072.0,Agenus' HerpV Therapeutic Genital Herpes Vaccine Meets Primary Endpoint in Randomized Phase 2 Trial ,2013-11-07 07:05:00-05:00,AGEN,neutral
42073.0,Morning Market Movers ,2013-10-08 09:53:00-04:00,AGEN,neutral
42074.0,"Agenus Shares Rise 16% Pre-Market, Hearing $19 PT from Maxim",2013-10-08 08:51:00-04:00,AGEN,positive
42075.0,Agenus Enters into Non-Exclusive License Agreement with VaxLogic for QS-21 Stimulon1 Adjuvant,2013-09-26 07:03:00-04:00,AGEN,positive
42076.0,Agenus Expands Registered Direct Offering by $3.5M,2013-09-19 08:59:00-04:00,AGEN,positive
42077.0,Agenus to Sell 2.17M Shares at $3/Unit,2013-09-18 09:44:00-04:00,AGEN,positive
42078.0,Morning Market Movers ,2013-09-17 09:53:00-04:00,AGEN,neutral
42079.0,Agenus Reports Positive Follow-on Phase 2 Results for Brain Cancer Vaccine,2013-09-17 07:04:00-04:00,AGEN,negative
42080.0,Morning Market Losers ,2013-09-05 10:03:00-04:00,AGEN,negative
42081.0,Agenus Inc. Reports Q2 EPS of $(0.40) Which May Not Compare $0.35 Est; Revenue of $807.0K Which May Not Compare $1.01M Est,2013-07-25 07:17:00-04:00,AGEN,neutral
42082.0,"Maxim Group Initiates Coverage on Agenus Inc. at Buy, Announces $19.00 PT",2013-06-18 13:34:00-04:00,AGEN,neutral
42083.0,Agenus Spike Higher,2013-06-18 13:30:00-04:00,AGEN,neutral
42084.0,Agenus Presents Positive Phase 2 Data from Agenus' Brain Cancer Vaccine,2013-05-01 11:22:00-04:00,AGEN,negative
42085.0,Agenus Inc. Reports Q1 EPS of $(0.35) vs $(0.23) Est; Revenue of $1.11M vs $1.07M Est,2013-04-24 07:58:00-04:00,AGEN,neutral
42086.0,"Agenus Eliminates $39M Senior Notes, Closes $10M in New Debt Financing",2013-04-16 07:29:00-04:00,AGEN,negative
42087.0,"JMP Securities Initiates Coverage on Agenus Inc. at Market Outperform, Announces $8.00 PT",2013-04-02 08:41:00-04:00,AGEN,positive
42088.0,UPDATE: Dawson James Reiterates Agenus Inc. at Buy After Rapid Phase II Trial Enrollment on HerbV,2013-03-12 15:06:00-04:00,AGEN,neutral
42089.0,Agenus Inc. Reports Q4 EPS of $(0.23) vs $(0.24) Est; Revenue of $1.09M vs $927.0K Est,2013-02-28 07:28:00-05:00,AGEN,neutral
42090.0,GlaxoSmithKline's Phase 3 Malaria Vaccine Study Meets Primary Endpoint,2012-11-09 06:07:00-05:00,AGEN,neutral
42091.0,Agenus Initiates Phase 2 Study of Genital Herpes Vaccine,2012-10-23 07:18:00-04:00,AGEN,neutral
42092.0,Aeras Signs Agreement with GSK to Jointly Develop TB Vaccine ,2012-10-10 06:18:00-04:00,AGEN,positive
42093.0,Agenus Announces Phase 3 Clinical Trial of GSK's Herpes Zoster Vaccine Candidate Containing Agenus' QS-21 Commences in Immunocompromised Patients  ,2012-07-18 07:07:00-04:00,AGEN,neutral
42094.0,Agenus Inc Plans To Move Forward With Randomized Trial Evaluating Efficacy Of HSPPC-96 In Glioblastoma Patients,2012-04-17 10:31:00-04:00,AGEN,neutral
42095.0,"Monday's NASDAQ Winners: RCON, AMPE, SAPX, AGEN",2012-03-20 12:24:00-04:00,AGEN,positive
42096.0,Market Update,2012-03-20 09:36:00-04:00,AGEN,neutral
42097.0,Agenus CFO Sharp to Step Down May 11,2012-03-20 07:05:00-04:00,AGEN,neutral
42098.0,Hearing Rodman & Renshaw Saying Agenus Could Be Takeover Target of GlaxoSmithKline,2012-03-07 11:01:00-05:00,AGEN,neutral
42099.0,Agenus Expands QS-21 License and Grants Right of First Negotiation to GlaxoSmithKline,2012-03-05 08:31:00-05:00,AGEN,positive
42100.0,"Small Biotechnology Stocks Roar, Profit Now",2012-01-26 14:03:00-05:00,AGEN,positive
42101.0,Stocks Hitting 52-Week Lows,2011-12-29 10:25:00-05:00,AGEN,negative
42102.0,A Peek Into The Market Before The Trading Starts,2011-12-20 07:13:00-05:00,AGEN,neutral
42103.0,Agenus and NewVac Enter Into Agreement in the Area of Personalized Cancer Vaccines  ,2011-12-20 06:57:00-05:00,AGEN,negative
42104.0,Agenus and ChemRar Enter Into Agreement in the Area of Personalized Cancer Vaccines ,2011-12-19 07:01:00-05:00,AGEN,negative
42105.0,"UPDATE: Global Hunter Securities Initiates Buy, $6 PT on Agenus ",2011-12-01 10:53:00-05:00,AGEN,positive
42106.0,"Global Hunter Securities Initiates Agenus at Buy, $6 PT",2011-12-01 09:06:00-05:00,AGEN,positive
42107.0,Agenus Resumes Trading ,2011-10-18 13:06:00-04:00,AGEN,neutral
42108.0,"Agenus Halted, Circuit Breaker Trigger",2011-10-18 13:01:00-04:00,AGEN,neutral
42109.0,Positive Results Shown With Agenus' QS-21 Stimulon Adjuvant in Phase 3 Trial of GlaxoSmithKline's Malaria Vaccine,2011-10-18 13:00:00-04:00,AGEN,positive
42110.0,Agenus Compliant With NASDAQ Listing Requirements  ,2011-10-17 13:10:00-04:00,AGEN,neutral
42111.0,Agenus Announces 1-for-6 Reverse Stock Split  ,2011-09-30 13:01:00-04:00,AGEN,neutral
42112.0,"Rodman & Renshaw Reiterates Agenus Market Outperform, $2 PT",2011-09-26 13:04:00-04:00,AGEN,neutral
42113.0,Clinical Data Published in Vaccine Demonstrate Robust Immune Response With Agenus' Herpes Vaccine Containing QS-21 Adjuvant ,2011-09-26 07:01:00-04:00,AGEN,positive
42114.0,MLV Initiates Coverage On Agenus ,2011-09-12 15:36:00-04:00,AGEN,neutral
42115.0,Hearing MLV Capital Making Positive Comments on Agenus; Stating the Company Has Several Near-Term Catalysts ,2011-09-12 15:14:00-04:00,AGEN,positive
42116.0,Agenus Prices Offering of 13.72M Shares at $0.51,2011-08-11 08:33:00-04:00,AGEN,positive
42117.0,Rodman & Renshaw Reiterates Outperform Rating on Agenus,2011-06-10 15:02:00-04:00,AGEN,neutral
42118.0,"Rodman & Renshaw Reiterates Agenus Market Perform, $2 PT",2011-06-10 13:23:00-04:00,AGEN,neutral
42119.0,New Data From Phase 2 Brain Cancer Study With Prophage Series G-200 (HSPPC-96) Shows Improved Overall Survival,2011-06-06 09:05:00-04:00,AGEN,negative
42120.0,Positive Rumors About Agenus Circulate (AGEN),2011-06-03 12:33:00-04:00,AGEN,positive
42121.0,Agenus Upgraded by Rodman & Renshaw (AGEN),2011-05-09 14:15:00-04:00,AGEN,neutral
42122.0,"TOP 15 Stocks To Watch this week- AAPL, BRK-A, BRK-B, BJ, C, F, GM, GPRO, IP, KND, N, NRTLQ, ONTY, SPPI, YRCW",2011-05-02 04:48:00-04:00,AGEN,positive
42123.0,"CEOWORLD Top 5 Analyst Calls of the Week- DNDN, INSP, MCP, SIRI, VICL",2011-05-02 03:32:00-04:00,AGEN,positive
42124.0,"Small Biotechnology Hot, Is Labopharm Next? ",2010-12-21 14:21:00-05:00,AGEN,neutral
42125.0,"Mid Market Movers (ZANE, RGDX, AEY, AGEN)",2010-05-11 15:14:00-04:00,AGEN,neutral
42126.0,Antigenics (AGEN) Strength Today Attributable To Potential Approval of Drug,2009-10-08 11:18:00-04:00,AGEN,positive
42127.0,"TheFortuneFinancial.com Free Market Research on SONS, BLUD, LKQX, CSUN, NIHD and AGEN",2009-08-07 07:08:00-04:00,AGEN,positive
